Reply to “Comment on ‘Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis’”

This publication has 16 references indexed in Scilit:

• Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway
  European Journal of Pharmacology, 2020
• Nanodrug with ROS and pH Dual‐Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation
  Advanced Science, 2020
• Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
  The Journal of Pharmacology and Experimental Therapeutics, 2019
• Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway
  Drug Design, Development and Therapy, 2018
• Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats
  European Journal of Pharmaceutical Sciences, 2014
• Genetic Characteristics of the Human Hepatic Stellate Cell Line LX-2
  PLOS ONE, 2013
• α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β
  Toxicology, 2011
• An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro
  Journal of Lipid Research, 2000
• Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor
  Journal of Biological Chemistry, 2000
• Transcriptional Activation of Transforming Growth Factor β1 and Its Receptors by the Kruppel-like Factor Zf9/Core Promoter-binding Protein and Sp1
  Journal of Biological Chemistry, 1998